Showing results (571-580 of 869) with videos related to

Sort By:
Pageof 87
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|November 1, 2000
13C and 1H NMR of 2,6-diaryl-1-hydroxy piperidin-4-one oximes; substituent effects on cis/trans ratio and conformational equilibriaE Díaz, H Barrios, F del Río Portilla, et al.
British Journal of Cancer|June 16, 2011
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated resultsJ Cassidy, S Clarke, E Díaz-Rubio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2011
Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacyC Twelves, W Scheithauer, J McKendrick, et al.
Archivos De La Sociedad Espanola De Oftalmologia|January 12, 2008
[Inter-observer variability in the diagnosis and classification of diabetic retinopathy through biomicroscopy]E Molina-Fernández, M S Valero-Moll, M Pedregal-González, et al.
Pediatric Cardiology|January 1, 1995
Diagnosis of Berry syndrome in an infant by two-dimensional and color Doppler echocardiographyC Alva-Espinosa, S Jiménez-Arteaga, E Díaz-Díaz, et al.
Journal of Chemotherapy (Florence, Italy)|November 26, 2008
Bevacizumab in combination with metronomic chemotherapy in patients with anthracycline- and taxane-refractory breast cancerJ A García-Sáenz, M Martín, A Calles, et al.
Medicina Intensiva|March 15, 2013
Oxidative stress in immunocompetent patients with severe community-acquired pneumonia. A pilot studyS Trefler, A Rodríguez, I Martín-Loeches, et al.
Oncology|February 23, 2013
Erlotinib versus pemetrexed for pretreated non-squamous non-small cell lung cancer patients in clinical practiceJ Zugazagoitia, J Puente, J L González-Larriba, et al.
Pageof 87